HOT TOPICS IN THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "HOT TOPICS IN THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE"

Transcription

1 9 t h S u m m e r S c h o o l o f t h e H e l l e n i c A t h e r o s c l e r o s i s S o c i e t y HOT TOPICS IN THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE June 30 th July 2 nd 2016, Royal Olympic Hotel, Athens SCIENTIFIC PROGRAM Thursday, June 30 t h : Registration desk open : Welcome address by the coordinators of the Summer School. E. Liberopoulos (Ioannina, Greece) K. Tziomalos Welcome address by the President of the Hellenic Atherosclerosis Society. A. Tselepis (Ioannina, : HDL functionality and cardiovascular risk. K. Kypreos (Patras, : The role of genetics in the diagnosis and management of cardiovascular diseases. M. Cariolou (Nicosia, Cyprus) : The role of proteomics in the diagnosis of cardiovascular disease. A. Vlahou (Athens, : Coffee break : Novel technologies in the management of cardiovascular diseases: monoclonal antibodies, antisense technology, mirna. A. Tselepis (Ioannina,

2 : Do we need other risk factors beside the established ones? K. Tziomalos Friday, July 1 s t : A patient with blood pressure 154/84 mmhg. Diagnostic approach. V. Kotsis : A patient with newly diagnosed stage 2 hypertension. Therapeutic approach. A. Karagiannis : A patient with blood pressure 220/120 mmhg in the Emergency Department. Α. Achimastos (Athens, : Coffee break : A patient with resistant hypertension. M. Doumas : An adolescent with blood pressure 154/94 mmhg. S. Stabouli : A patient with a suspicious electrocardiogram in the outpatient clinics. C. Pitsavos (Athens, : Lunch break

3 : A 45-year old patient with LDL cholesterol 210 mg/dl. Μ. Elisaf (Ioannina, : A patient with LDL cholesterol 130 mg/dl, triglycerides 320 mg/dl and type 2 diabetes mellitus. V. G. Athyros (Thessaloniki, : A patient with prediabetes and LDL cholesterol 150 mg/dl. Ε. Bilianou (Athens, : Coffee break : A patient at intermediate cardiovascular risk with elevated Lp(a). Ε. Ganotakis (Heraklion, : A patient with coronary heart disease who develops myalgias after treatment with atorvastatin 40 mg/day. N. Katsiki : LDL-cholesterol. How low should we go and with which agent(s)? D. P. Mikhailidis (London, UK) : Sample size calculation and selection of the appropriate statistical method in clinical research. D. Panagiotakos (Athens, Saturday, July 2 n d : A patient with body mass index 32 kg/m 2. Dietary recommendations. M. Yannakoulia (Athens,

4 : A patient with type 2 diabetes mellitus on metformin with HbA 1c 8%. T. Alexandridis (Patras, : Initiation and intensification of insulin treatment. S. Pappas (Athens, : Coffee break : A patient with type 2 diabetes mellitus and established cardiovascular disease. Options and target of antidiabetic treatment. N. Papanas (Alexandroupolis, : A patient with type 2 diabetes mellitus without angina. Should he undergo evaluation for coronary heart disease? TBD : A patient with type 2 diabetes mellitus and painful neuropathy. J. Doupis (Athens, : Lunch break : Acid-base and electrolyte disorders induced by agents used in the management of cardiovascular diseases. G. Liamis (Ioannina, : A patient with an acute coronary syndrome one year ago. Options for antiplatelet treatment. TBD : A patient with cryptogenic stroke. G. Ntaios (Larisa,

5 : Coffee break : A patient with angina. Diagnostic approach. C. Chrysohoou (Athens, : A 70-year old patient with atrial fibrillation and hypertension. Options of anticoagulant treatment. V. Nikolaou (Athens, : A patient with deep vein thrombosis. Ε. Liberopoulos (Ioannina, : A patient with a recent acute coronary syndrome. Which is the optimal antiplatelet regimen? TBD : End of Summer School - Conclusions

Lifestyle and pharmacological interventions for the management of cardiovascular disease: dilemmas and perspectives

Lifestyle and pharmacological interventions for the management of cardiovascular disease: dilemmas and perspectives 7 t h Summer School of the Hellenic Atherosclerosis Society Lifestyle and pharmacological interventions for the management of cardiovascular disease: dilemmas and perspectives June 26 28, 2014, Crowne

More information

DIABETES: STRATEGIES AND PERSPECTIVES: 2012

DIABETES: STRATEGIES AND PERSPECTIVES: 2012 HELLENIC ASSOCIATION FOR THE STRATEGIC STUDIES OF DIABETES AND THE DIABETES CENTRE OF NIMTS HOSPITAL (ATHENS - GREECE) DIABETES: STRATEGIES AND PERSPECTIVES: 2012 17-19 May 2012 Hotel Poseidon Resort Loutraki,

More information

REACH Risk Evaluation to Achieve Cardiovascular Health

REACH Risk Evaluation to Achieve Cardiovascular Health Dyslipidemia and type 1 diabetes mellitus History: A 15-year-old girl is seen in the endocrinology clinic for a routine follow-up visit for type 1 diabetes. She was diagnosed with diabetes at 12 years

More information

REACH Risk Evaluation to Achieve Cardiovascular Health

REACH Risk Evaluation to Achieve Cardiovascular Health Dyslipidemia and type 2 diabetes mellitus History: A 17-year-old Hispanic female patient is seen for a routine clinic follow-up visit. She was diagnosed with type 2 diabetes 6 months ago. Her hemoglobin

More information

Diabetes and Heart Disease

Diabetes and Heart Disease Diabetes and Heart Disease Diabetes and Heart Disease According to the American Heart Association, diabetes is one of the six major risk factors of cardiovascular disease. Affecting more than 7% of the

More information

Rx Updates New Guidelines, New Medications What You Need to Know

Rx Updates New Guidelines, New Medications What You Need to Know Rx Updates New Guidelines, New Medications What You Need to Know Maria Pruchnicki, PharmD, BCPS, BCACP, CLS Associate Professor of Clinical Pharmacy OSU College of Pharmacy Background scope and impact

More information

Assmann Foundation for Prevention 1

Assmann Foundation for Prevention 1 Clinical guidelines usually recommend that the level of high density lipoprotein cholesterol (HDL-C) should be measured. It is frequently argued that HDL-C levels below 35 mg/dl are causally associated

More information

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

More information

Nutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT

Nutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT 1 Nutrition Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT 2 Type 2 Diabetes: A Growing Challenge in the Healthcare Setting Introduction and background of type 2 diabetes:

More information

Pediatric Metabolic Syndrome

Pediatric Metabolic Syndrome University of Michigan Hospitals and Health Centers Pediatric Metabolic Syndrome A growing epidemic Shannon Russell Dietetic Intern June 2012 Overview Causes Risk Factors Signs and Symptoms Identification/Diagnosis

More information

EUROASPIRE II. European Action on Secondary and Primary Prevention through Intervention to Reduce Events

EUROASPIRE II. European Action on Secondary and Primary Prevention through Intervention to Reduce Events II European Action on Secondary and Primary Prevention through Intervention to Reduce Events Euro Heart Survey Programme European Society of Cardiology-ESC 1 2 Priorities of Coronary Heart Disease Prevention

More information

Guidelines for the management of hypertension in patients with diabetes mellitus

Guidelines for the management of hypertension in patients with diabetes mellitus Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes

More information

Center of Excellence in Naturopathic Cardiovascular Medicine

Center of Excellence in Naturopathic Cardiovascular Medicine Introducing the Center of Excellence in Naturopathic Cardiovascular Medicine The Heart & Lung Wellness program at Center for Natural Medicine and National College of Natural Medicine WHO WE ARE A Center

More information

Learning Objectives Patient Care: Prevention/General Cardiology

Learning Objectives Patient Care: Prevention/General Cardiology Rotation: Director: Faculty: Preventive /General Cardiology Emily G. Kurtz, M.D./Waleed Irani, M.D. Prevention: Jeff Boord, M.D., Sergio Fazio, M.D., Emily G. Kurtz, M.D., MacRae Linton, M.D., David Maron,

More information

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below Name: generic (trade) Rivaroxaban (Xarelto ) HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below What it is Indications

More information

Effect of Exercise on BMI and Biochemical Profile of Selected Obese Diabetic Women

Effect of Exercise on BMI and Biochemical Profile of Selected Obese Diabetic Women Effect of Exercise on BMI and Biochemical Profile of Selected Obese Diabetic Women Nazni, P. *, Poongodi Vijayakumar, T. ** & Angamuthu, K. *** * Lecturer, Department of Food Science, Periyar University,

More information

South African Cholesterol Guidelines Compared

South African Cholesterol Guidelines Compared South African Cholesterol Guidelines Compared Jacqueline van Schoor, Amayeza Info Centre While infectious diseases are currently the leading cause of death in South Africa, cardiovascular disease (CVD)

More information

Diabetes mellitus is a metabolic disorder of glucose metabolism with many causes and forms.

Diabetes mellitus is a metabolic disorder of glucose metabolism with many causes and forms. Chapter 20 Diabetes Mellitus Chapter 20 Lesson 20.1 Key Concept Diabetes mellitus is a metabolic disorder of glucose metabolism with many causes and forms. About Diabetes 20.8 million Americans have diabetes

More information

REACH Risk Evaluation to Achieve Cardiovascular Health

REACH Risk Evaluation to Achieve Cardiovascular Health Dyslipidemia and obesity History: A 13-year-old girl is seen for a routine clinic follow-up visit. She has been previously healthy, but her growth curve shows increasing body mass index (BMI) percentiles

More information

Leading cause of death for men and women. Coronary heart disease (CHD) most common. Diet Physical inactivity Obesity Alcohol

Leading cause of death for men and women. Coronary heart disease (CHD) most common. Diet Physical inactivity Obesity Alcohol CHOLESTEROL AND STATINS HEART DISEASE Leading cause of death for men and women Coronary heart disease (CHD) most common Terri Giordano MSN, CRNP, CORLN The Children s Hospital of Philadelphia Division

More information

Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background. CAPA 2015 Annual Conference

Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background. CAPA 2015 Annual Conference Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group Learning Objectives To accurately make the diagnosis of pre-diabetes/metabolic syndrome To understand the prevalence

More information

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities Obesity Role of Body Weight Reduction in JMAJ 48(1): 47 1, 2 Hideaki BUJO Professor, Department of Genome Research and Clinical Application (M6) Graduate School of Medicine, Chiba University Abstract:

More information

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused

More information

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process

More information

ESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease

ESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease Diabetes, prediabetes and cardiovascular disease Classes of recommendations Levels of evidence Recommended treatment targets for patients with diabetes and CAD Definition, classification and screening

More information

High Blood Cholesterol

High Blood Cholesterol National Cholesterol Education Program ATP III Guidelines At-A-Glance Quick Desk Reference 1 Step 1 2 Step 2 3 Step 3 Determine lipoprotein levels obtain complete lipoprotein profile after 9- to 12-hour

More information

Intelligent Monitoring Report. Greenford Avenue Family Health Practice 322 Greenford Avenue London W7 3AH

Intelligent Monitoring Report. Greenford Avenue Family Health Practice 322 Greenford Avenue London W7 3AH Greenford Avenue Family Health Practice 322 Greenford Avenue London W7 3AH Intelligent Monitoring (IM) Report GP IM is an initial list of 37 indicators that currently cover three of our five key questions

More information

Clinical Practice Guidelines for Diabetes Management

Clinical Practice Guidelines for Diabetes Management Clinical Practice Guidelines for Diabetes Management Diabetes is a disease in which blood glucose levels are above normal. Over the years, high blood glucose damages nerves and blood vessels, which can

More information

Decoding Your Lab Report

Decoding Your Lab Report Decoding Your Lab Report Lab reports are a routine but mysterious part of medical visits. Whether you are being diagnosed with diabetes for the first time or getting your A1C test for the hundredth time,

More information

Leicester Diabetes Centre 2012

Leicester Diabetes Centre 2012 Therapeutic Inertia Dr Samuel Seidu. Declaration of interests Sam Seidu has acted as advisory board member and/or speaker for Novartis, Janssen, Novo Nordisk, Lilly, Boehringer Ingelheim, MSD, Amgen, Astra

More information

Welchol (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes

Welchol (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Takashi Shoda, President and Representative Director (Code no.: 4568, First Section, Tokyo, Osaka and Nagoya Stock Exchanges)

More information

Who typically has Metabolic Syndrome? According to the American Heart Association, three groups of people often have metabolic syndrome:

Who typically has Metabolic Syndrome? According to the American Heart Association, three groups of people often have metabolic syndrome: Metabolic Syndrome By Seth Bilazarian, MD, FACC, FSCAI, RPVI Clinical and Intervential Cardiologist What is the Metabolic Syndrome? The Metabolic Syndrome is a collection of five problems that greatly

More information

MY TYPE 2 DIABETES NUMBERS

MY TYPE 2 DIABETES NUMBERS BLOOD SUGAR MANAGEMENT GUIDE MY TYPE 2 DIABETES NUMBERS Understanding and Tracking the ABCs of Type 2 Diabetes 1 BLOOD MY TYPE SUGAR 2 DIABETES MANAGEMENT ABC NUMBERS GUIDE When you have type 2 diabetes,

More information

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Effects of a fixed combination of the ACE inhibitor, perindopril,

More information

Insulin Resistance and Pre-diabetes

Insulin Resistance and Pre-diabetes 1 of 6 11/17/2009 9:38 PM Insulin Resistance and Pre-diabetes What is insulin resistance? What causes insulin resistance? Metabolic Syndrome What is pre-diabetes? What are the symptoms of insulin resistance

More information

4/4/2013. Mike Rizo, Pharm D, MBA, ABAAHP THE PHARMACIST OF THE FUTURE? METABOLIC SYNDROME AN INTEGRATIVE APPROACH

4/4/2013. Mike Rizo, Pharm D, MBA, ABAAHP THE PHARMACIST OF THE FUTURE? METABOLIC SYNDROME AN INTEGRATIVE APPROACH METABOLIC SYNDROME AN INTEGRATIVE APPROACH AN OPPORTUNITY FOR PHARMACISTS TO MAKE A DIFFERENCE Mike Rizo, Pharm D, MBA, ABAAHP THE EVOLUTION OF THE PHARMACIST 1920s 1960s 2000s THE PHARMACIST OF THE FUTURE?

More information

ICD 10 CM. Diabetes Mellitus Hypertension

ICD 10 CM. Diabetes Mellitus Hypertension ICD 10 CM Diabetes Mellitus Hypertension 1 Legal Stuff The information provided here is personal opinion only and should not be construed as legal advice. Each provider is ultimately responsible for bills

More information

Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology

Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology Chapter 4: Endocrine, Nutritional, and Metabolic Diseases (E00-E89) The diabetes mellitus codes are combination codes

More information

Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media

Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media News Release Not intended for U.S. and UK Media Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer Forms Collaboration with Academic and Governmental Institutions for Rivaroxaban

More information

Do You Know The Important Risk Factor and Fitness Assessment Numbers? Jonathan N. Mike M.S. and Len Kravitz, Ph.D.

Do You Know The Important Risk Factor and Fitness Assessment Numbers? Jonathan N. Mike M.S. and Len Kravitz, Ph.D. Do You Know The Important Risk Factor and Fitness Assessment Numbers? Jonathan N. Mike M.S. and Len Kravitz, Ph.D. Introduction One of the principal areas of concern for exercise professionals is assessing,

More information

Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence

Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Guidelines Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Stroke/TIA Nearly 700,000 ischemic strokes and 240,000 TIAs every year in the United States Currently, the risk for

More information

Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment

Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment What does that mean for you? Your healthcare provider has determined that you may be at risk for cardiovascular disease (CVD).

More information

Diabetes Passport. Your Journey to Wellness

Diabetes Passport. Your Journey to Wellness Diabetes Passport Your Journey to Wellness This Diabetes Passport will help you track your health in 4 key areas for people living with diabetes: Body Mass Index Blood Sugar (Blood Glucose) Blood Cholesterol

More information

in Singapore and provide valuable inputs for the the Ministry of Health conducts periodic, population-

in Singapore and provide valuable inputs for the the Ministry of Health conducts periodic, population- 5 Main Report H E A LT H SURVEY Introduction 1 Introduction N AT I O N A L Background The Epidemiology and Disease Control Division of in Singapore and provide valuable inputs for the the Ministry of

More information

Bayer Initiates Rivaroxaban Phase III Study to Support Dose Selection According to Individual Benefit-Risk Profile in Long- Term VTE Prevention

Bayer Initiates Rivaroxaban Phase III Study to Support Dose Selection According to Individual Benefit-Risk Profile in Long- Term VTE Prevention Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Long-term prevention of venous blood clots (VTE): Bayer Initiates Rivaroxaban

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE 1 NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Guideline title SCOPE Hypertension: clinical management of primary hypertension in adults 1.1 Short title Hypertension (partial update) 2 The remit

More information

AHA/ASA Guidelines on Prevention of Recurrent Stroke

AHA/ASA Guidelines on Prevention of Recurrent Stroke AHA/ASA Guidelines on Prevention of Recurrent Stroke MARA LAMBERT Guideline source: American Heart Association/American Stroke Association Evidence rating system used? Yes Literature search described?

More information

An Overview and Guide to Healthy Living with Type 2 Diabetes

An Overview and Guide to Healthy Living with Type 2 Diabetes MEETING YOUR GOALS An Overview and Guide to Healthy Living with Type 2 Diabetes MEETING YOUR GOALS This brochure was designed to help you understand the health goals to live a healthy lifestyle with type

More information

YOUR GUIDE TO. Lowering The Risk of Heart Attack and Stroke

YOUR GUIDE TO. Lowering The Risk of Heart Attack and Stroke YOUR GUIDE TO Lowering The Risk of Heart Attack and Stroke The Mercy Health Heart Institute team is focused on helping you keep your heart healthy. As part of this effort, it s important for you to know

More information

GENDER PERSPECTIVE IN CARDIOVASCULAR PHARMACOLOGY & PREVENTION

GENDER PERSPECTIVE IN CARDIOVASCULAR PHARMACOLOGY & PREVENTION GENDER PERSPECTIVE IN CARDIOVASCULAR PHARMACOLOGY & PREVENTION Porter Avital, M.D Head of intermediate ICCU Dept. of Cardiology, Rabin Medical Center- Beilinson Campus, Petah Tiqva, Israel And the Tel

More information

PRESCRIBING GUIDELINES FOR LIPID LOWERING TREATMENTS for SECONDARY PREVENTION

PRESCRIBING GUIDELINES FOR LIPID LOWERING TREATMENTS for SECONDARY PREVENTION Hull & East Riding Prescribing Committee PRESCRIBING GUIDELINES FOR LIPID LOWERING TREATMENTS for SECONDARY PREVENTION For guidance on Primary Prevention please see NICE guidance http://www.nice.org.uk/guidance/cg181

More information

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering

More information

VASCULAR SURGERY. 4. Assess the vascular system by appropriate skills in history-taking and in clinical examination.

VASCULAR SURGERY. 4. Assess the vascular system by appropriate skills in history-taking and in clinical examination. VASCULAR SURGERY PGY-1 Medical Knowledge 1. Describe human arterial and venous anatomy. 2. Describe basic arterial and venous hemodynamics. 3. Review the basic clinical manifestations of vascular disorders.

More information

DIABETES GLOSSARY OF TERMS

DIABETES GLOSSARY OF TERMS DIABETES GLOSSARY OF TERMS Diabetes is a common condition, which most people have some understanding of, but when you listen to people talk about it, you may feel as if it has language of its own full

More information

Prevention of Cardiovascular Disease in Children with Diabetes

Prevention of Cardiovascular Disease in Children with Diabetes Prevention of Cardiovascular Disease in Children with Diabetes Stephen R. Daniels, MD, PhD Department of Pediatrics University of Colorado School of Medicine The Children s Hospital Anschutz Medical Campus

More information

Oregon Health Study. Report of Findings. When we measured your weight, it was <X, Look- up>.

Oregon Health Study. Report of Findings. When we measured your weight, it was <X, Look- up>. Oregon Health Study Report of Findings Dear , Recently, as part of the Oregon Health Study, you had a health screening. This letter is to inform you about the results of that screening. While these

More information

Prediabetes: A Woman s Perspective

Prediabetes: A Woman s Perspective Prediabetes: A Woman s Perspective AMERICAN COLLEGE OF ENDOCRINOLOGY CONSENSUS STATEMENT ON THE DIAGNOSIS AND MANAGEMENT OF PRE-DIABETES IN THE CONTINUUM OF HYPERGLYCEMIA Joanne Kaiser-Smith, D.O., FACOI,

More information

What is the ideal A1C goal for people with diabetes? a) Under 7% b) 6.5% or less c) 4%- 6%

What is the ideal A1C goal for people with diabetes? a) Under 7% b) 6.5% or less c) 4%- 6% A1C Test Quiz: Are You in the Know About the A1C Test? The dreaded A1C test. Twice or more a year, you have to face this "judge" of all you have done the two or three months before. No matter how hard

More information

CASE B1. Newly Diagnosed T2DM in Patient with Prior MI

CASE B1. Newly Diagnosed T2DM in Patient with Prior MI Newly Diagnosed T2DM in Patient with Prior MI 1 Our case involves a gentleman with acute myocardial infarction who is newly discovered to have type 2 diabetes. 2 One question is whether anti-hyperglycemic

More information

The NIHR Diabetes Research Network

The NIHR Diabetes Research Network The NIHR Diabetes Research Network Des Johnston, Imperial College London The is part of the National Institute for Health Research Clinical Research Network Website: www.ukdrn.org Email: drninfo@ukdrn.org

More information

TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU

TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU Objectives: 1. To discuss epidemiology and presentation

More information

my Complete Cholesterol Profile and Action Plan

my Complete Cholesterol Profile and Action Plan my Complete Cholesterol Profile and Action Plan Your healthcare provider, along with this brochure, can help you better understand your Complete Cholesterol Profile, which may help you improve your cholesterol

More information

Acquired Heart Disease: Prevention and Treatment

Acquired Heart Disease: Prevention and Treatment Acquired Heart Disease: Prevention and Treatment Prevention and Treatment Sharon L. Roble, MD Assistant Professor Adult Congenital Heart Program The Ohio State University/Nationwide Children s Hospital

More information

Treatment of diabetes In order to survive, people with type 1 diabetes must have insulin delivered by a pump or injections.

Treatment of diabetes In order to survive, people with type 1 diabetes must have insulin delivered by a pump or injections. National Diabetes Statistics What is diabetes? Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action, or both.

More information

Primary Care Management of Women with Hyperlipidemia. Julie Marfell, DNP, BC, FNP, Chairperson, Department of Family Nursing

Primary Care Management of Women with Hyperlipidemia. Julie Marfell, DNP, BC, FNP, Chairperson, Department of Family Nursing Primary Care Management of Women with Hyperlipidemia Julie Marfell, DNP, BC, FNP, Chairperson, Department of Family Nursing Objectives: Define dyslipidemia in women Discuss the investigation process leading

More information

Metabolic Syndrome with Prediabetic Factors Clinical Study Summary Concerning the Efficacy of the GC Control Natural Blood Sugar Support Supplement

Metabolic Syndrome with Prediabetic Factors Clinical Study Summary Concerning the Efficacy of the GC Control Natural Blood Sugar Support Supplement CLINICALLY T E S T E D Natural Blood Sugar Metabolic Syndrome with Prediabetic Factors Clinical Study Summary Concerning the Efficacy of the GC Control Natural Blood Sugar Metabolic Syndrome with Prediabetic

More information

New Medicare Preventive

New Medicare Preventive New Medicare Preventive Services Screening Tests You Can Perform in the Office Charles B. Root, PhD Medicare is finally getting serious about preventive services. Until now, the limited preventive testing

More information

D I D Y O U K N O W? D I A B E T E S R E S O U R C E G U I D E. Blindness Heart Disease Strokes Kidney Failure Amputation

D I D Y O U K N O W? D I A B E T E S R E S O U R C E G U I D E. Blindness Heart Disease Strokes Kidney Failure Amputation D I D Y O U K N O W? D I A B E T E S R E S O U R C E G U I D E Diabetes is a serious disease that can lead to Blindness Heart Disease Strokes Kidney Failure Amputation Diabetes kills almost 210,000 people

More information

Know Your Numbers. Your guide to maintaining good health. Important Information from Providence Medical Center and Saint John Hospital

Know Your Numbers. Your guide to maintaining good health. Important Information from Providence Medical Center and Saint John Hospital Know Your Numbers Your guide to maintaining good health Important Information from Providence Medical Center and Saint John Hospital If it has been awhile since your last check up and you are searching

More information

HEDIS CY2012 New Measures

HEDIS CY2012 New Measures HEDIS CY2012 New Measures TECHNICAL CONSIDERATIONS FOR NEW MEASURES The NCQA Committee on Performance Measurement (CPM) approved five new measures for HEDIS 2013 (CY2012). These measures provide feasible

More information

Nutrition: Knowing Your Total Cholesterol

Nutrition: Knowing Your Total Cholesterol Nutrition: Knowing Your Total Cholesterol A number of factors can increase your risk for coronary heart disease. To make an accurate assessment your doctor will determine your lipid profile, overall health,

More information

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs A Patient s Guide to Primary and Secondary Prevention of PATIENT EDUCATION GUIDE What Is Cardiovascular Disease? Cardiovascular disease (CVD) is a broad term that covers any disease of the heart and circulatory

More information

CASE STUDY. Beta-Thalassemia, Hyperlipoproteinemia(a), and Metabolic Syndrome: Its Low-Cost Holistic Therapy

CASE STUDY. Beta-Thalassemia, Hyperlipoproteinemia(a), and Metabolic Syndrome: Its Low-Cost Holistic Therapy THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 13, Number 2, 2007, pp. 287 289 Mary Ann Liebert, Inc. DOI: 10.1089/acm.2006.6359 CASE STUDY Beta-Thalassemia, Hyperlipoproteinemia(a), and

More information

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors News Release For use outside the US and UK only Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer s Xarelto Approved in the EU for the Prevention of Stroke in Patients

More information

Vascular Risk Reduction: Addressing Vascular Risk

Vascular Risk Reduction: Addressing Vascular Risk Vascular Risk Reduction: Addressing Vascular Risk Vascular Risk Reduction (VRR) Welcome! Presentation & Activities Focus: Managing known risk factors for vascular disease. Engage, collaborate and have

More information

Challenges in Glycemic Control in Adult and Geriatric Patients. Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner

Challenges in Glycemic Control in Adult and Geriatric Patients. Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner Challenges in Glycemic Control in Adult and Geriatric Patients Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner Provide an overview of diabetes prevalence; discuss challenges and barriers

More information

WorkSmart WorkSmart myhealth WorkSmart A1C LDL TrigLyCeriDes CoTinine ToTAL hdl ToTAL ChoLesTeroL ChoLesTeroL-hDL ratio

WorkSmart WorkSmart myhealth WorkSmart A1C LDL TrigLyCeriDes CoTinine ToTAL hdl ToTAL ChoLesTeroL ChoLesTeroL-hDL ratio is designed for the workplace looking for a single, comprehensive set of tests that establish baseline laboratory values for wellness and disease management programs. The Test Package describes the normal

More information

Diabetes, Type 2. RelayClinical Patient Education Sample Topic Diabetes, Type 2. What is type 2 diabetes? How does it occur?

Diabetes, Type 2. RelayClinical Patient Education Sample Topic Diabetes, Type 2. What is type 2 diabetes? How does it occur? What is type 2 diabetes? Type 2 diabetes is a disorder that happens when your body does not make enough insulin or is unable to use its own insulin properly. The inability to use insulin is called insulin

More information

WHAT DOES DYSMETABOLIC SYNDROME MEAN?

WHAT DOES DYSMETABOLIC SYNDROME MEAN? ! WHAT DOES DYSMETABOLIC SYNDROME MEAN? Dysmetabolic syndrome (also referred to as syndrome X, insulin resistance syndrome, and metabolic syndrome ) is a condition in which a group of risk factors for

More information

Baskets of Care Diabetes Subcommittee

Baskets of Care Diabetes Subcommittee Baskets of Care Diabetes Subcommittee Disclaimer: This background information is not intended to be a comprehensive scientific discussion of the topic, but rather an attempt to provide a baseline level

More information

Diabetes Mellitus 1. Chapter 43. Diabetes Mellitus, Self-Assessment Questions

Diabetes Mellitus 1. Chapter 43. Diabetes Mellitus, Self-Assessment Questions Diabetes Mellitus 1 Chapter 43. Diabetes Mellitus, Self-Assessment Questions 1. A 46-year-old man presents for his annual physical. He states that he has been going to the bathroom more frequently than

More information

Objectives. Introduction

Objectives. Introduction 1 Lab 1: Diabetes Reading 13 th Edition Hole s Diabetes Clinical Application & From Science To Technology (pages 516-517) Table Appendix C (pages 928-930) Objectives 1. To define diabetes mellitus. 2.

More information

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) March 2014 2014 MVP Health Care, Inc. CHAPTER 9 CHAPTER SPECIFIC CATEGORY CODE BLOCKS I00-I02 Acute rheumatic fever I05-I09 Chronic rheumatic heart

More information

European Commission Approves EFIENT (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI

European Commission Approves EFIENT (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Takashi Shoda, President and Representative Director (Code no.: 4568, First Section, Tokyo, Osaka and Nagoya Stock Exchanges)

More information

SUMMARY OF CHANGES TO QOF 2015/16 - ENGLAND CLINICAL

SUMMARY OF CHANGES TO QOF 2015/16 - ENGLAND CLINICAL SUMMARY OF CHANGES TO QOF 2015/1 - ENGLAND KEY No change Retired/replaced Wording and/or change Point or threshold change Indicator ID change 14/15 QOF ID 15/1 QOF ID NICE ID Indicator wording Changes

More information

Obstructive Sleep Apnea and Heart Disease Phoebe A. Ashley, M.D., FACC

Obstructive Sleep Apnea and Heart Disease Phoebe A. Ashley, M.D., FACC Obstructive Sleep Apnea and Heart Disease Phoebe A. Ashley, M.D., FACC Oregon Cardiology, P.C. Medical Director, OHVI Cardiovascular Wellness & Rehabilitation Program 2 Tonight s Agenda 1. What is Cardiovascular

More information

Prevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012

Prevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012 Prevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012 In 2002, SETMA began a relationship with Joslin Diabetes

More information

Dear BESTmed Member. BESTmed Medicine Management

Dear BESTmed Member. BESTmed Medicine Management Dear BESTmed Member Please find attached the chronic medicine application form Please refer to the following important information regarding the chronic medicine benefits application process 1 Complete

More information

Vascular Surgery. Peripheral Arterial Disease

Vascular Surgery. Peripheral Arterial Disease Vascular Surgery Peripheral Arterial Disease The Department of Surgery sees patients for a wide range of surgical services. These include Colorectal, Endocrine, Breast, Upper GI, Bariatrics, Hepatobiliary,

More information

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest EXPLAINING

More information

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.

More information

Saving healthcare costs by implementing new genetic risk tests for early detection of cancer and prevention of cardiovascular diseases

Saving healthcare costs by implementing new genetic risk tests for early detection of cancer and prevention of cardiovascular diseases Saving healthcare costs by implementing new genetic risk tests for early detection of cancer and prevention of cardiovascular diseases Jeff Gulcher, MD PhD Chief Scientific Officer and co-founder decode

More information

Diabetes and Stroke. Understanding the connection between diabetes and the increased risk of stroke

Diabetes and Stroke. Understanding the connection between diabetes and the increased risk of stroke Diabetes and Stroke Understanding the connection between diabetes and the increased risk of stroke Make the Connection Almost 26 million people in the U.S. roughly 8 percent of the population have diabetes.

More information

PUBLIC HEALTH GUIDANCE SCOPE

PUBLIC HEALTH GUIDANCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE PUBLIC HEALTH GUIDANCE 1 Guidance title SCOPE Prevention of type 2 diabetes: prevention of the progression of pre-diabetes to type 2 diabetes among

More information

MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY

MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY In order to improve the efficiency of PINNACLE Registry data analytics, a missing data analysis has been conducted on PINNACLE Registry data

More information

Insulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks

Insulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks Background: Insulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks Final Background and Scope November 19, 2015 The Centers for Disease Control

More information

Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of Unmet Medical Need in Arterial Thromboembolism

Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of Unmet Medical Need in Arterial Thromboembolism Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of

More information

With unrestricted educational grant from

With unrestricted educational grant from HOTEL MAKSOUD PLAZA SÃO PAULO SP BRASIL OCTOBER 22-23, 2009 Organization With unrestricted educational grant from As the President of the Brazilian Society of Internal Medicine and the Brazilian Clinical

More information

Preventive Health Unit Cardiovascular disease risk in Queensland : blood pressure, cholesterol, obesity and diabetes

Preventive Health Unit Cardiovascular disease risk in Queensland : blood pressure, cholesterol, obesity and diabetes Preventive Health Unit Cardiovascular disease risk in Queensland 2011 12: blood pressure, cholesterol, obesity and diabetes About this report This report is designed for a technical audience, and assumes

More information

Endorsement Summary: Cardiovascular Measures

Endorsement Summary: Cardiovascular Measures January 2012 Purpose of the Project The human and financial costs of cardiovascular disease are enormous. Heart disease is the leading cause of death for men and women in the United States and was estimated

More information